Argenx

This study followed adults with moderate-to-severe bullous pemphigoid, a rare autoimmune condition that causes painful skin blisters, to see how safe and effective efgartigimod injections were over a longer period. Participants who completed a previous 36-week study could receive…

This study aimed to evaluate the long-term safety and effectiveness of efgartigimod in adults with post-COVID POTS, a condition causing dizziness and rapid heartbeat when standing. The trial enrolled 33 participants who had completed a previous 24-week study, giving them continue…

This study tested whether regular injections of an experimental drug called efgartigimod could help adults with active, moderate-to-severe Thyroid Eye Disease. The trial compared the drug against placebo injections and measured improvements in eye bulging, double vision, and qual…

This study tested whether a new injectable medication called efgartigimod could help adults with active, moderate-to-severe Thyroid Eye Disease. It compared the drug against a placebo injection to see if it could reduce eye bulging and improve quality of life. The trial was stopp…